The Los Angeles Post
U.S. World Business Lifestyle
Today: March 16, 2025
Today: March 16, 2025
Bhanvi Satija

Bhanvi Satija

Staff Writer

Latest From Bhanvi Satija

Business|Finance|Stock Markets|US

Pfizer lifts profit forecast as CEO sees reason for optimism in 2024

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting

Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Business|Finance|Health|Stock Markets

Sarepta surges as investors cheer expanded use of gene therapy

Sarepta Therapeutics shares surged as much as 40% to a more than three-year high on Friday as an expanded use approval cemented its dominant position in

Health|Science

Novo's Wegovy induces higher weight loss in women than men with same heart condition, study shows

Novo Nordisk's popular obesity drug Wegovy helped women with a common heart disease lose more weight than men who had the same

Novo's Wegovy induces higher weight loss in women than men with same heart condition, study shows
Health|Science

US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug

An FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on Thursday revealed no red flags, but raised

US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say

Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say
News|US

Walgreens cuts profit view, to shut more stores on spending hit

(This June 27 story has been corrected to drop a reference to Walgreens closing 700 stores in the U.S. as the number was already reported, in the headline

Walgreens cuts profit view, to shut more stores on spending hit
Business|Finance|Health|US

Drugmakers kick off industry conference with two cancer deals

Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting

Drugmakers kick off industry conference with two cancer deals
Business|Health|Science

Alnylam's drug cuts risk of death, heart issues in key study, shares jump

Alnylam Pharmaceuticals said its drug vutrisiran reduced deaths and cardiovascular events by a third in a study involving patients with a rare heart disease, sending the

Business|Economy|Finance

J&J beats Wall St estimates on strong drug sales ahead of Stelara competition

(This July 17 story has been corrected to clarify that the CFO did not suggest that pending Stelara insurance contracts would be 'favorable,' in paragraph 4) By Patrick Wingrove and Bhanvi Satija (

J&J beats Wall St estimates on strong drug sales ahead of Stelara competition
Business|Health

Boehringer-GoodRx partner to offer Humira rival at 92% discount

A close copy version of Abbvie's blockbuster arthritis drug Humira will be available at a 92% discount to its list price on the GoodRx website, the digital healthcare

Boehringer-GoodRx partner to offer Humira rival at 92% discount
Economy|US

US drug industry middlemen defend business model amid accusations of raising patient costs

U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a Congressional hearing on Tuesday after committee members

US drug industry middlemen defend business model amid accusations of raising patient costs
Business|Finance|Stock Markets|US

Dexcom plunges as revenue forecast cut spooks investors

Dexcom shares closed more than 40% lower on Friday after the glucose monitor maker slashed its annual revenue forecast due to the fallout from a salesforce revamp,

Business|Finance|Health|Stock Markets

Pfizer lifts profit forecast as investors await turnaround

Pfizer raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its

Pfizer lifts profit forecast as investors await turnaround
Health|News|Science|World

WHO to convene emergency committee to assess international risk from mpox outbreak

The head of the World Health Organization said on Wednesday an emergency committee will be convened to discuss whether the current mpox outbreak in the

WHO to convene emergency committee to assess international risk from mpox outbreak
Business|Finance|Health

Weight-loss drug powers Lilly results, 2024 forecast raised by $3 billion

Increased manufacturing capacity for Eli Lilly's highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by

Health|News|Science|World

WHO declares mpox a global public health emergency for second time in two years

The World Health Organization on Wednesday declared mpox a global public health emergency for the second time in two years, following an outbreak of the

WHO declares mpox a global public health emergency for second time in two years
Europe|Health|News|World

More imported cases of new mpox strain in Europe expected, public health agency says

More imported cases of a new mpox strain will appear in Europe in the coming weeks but the risk of sustained transmission remains low, the head of

More imported cases of new mpox strain in Europe expected, public health agency says
Europe|Health|News

EU public health body lifts mpox risk alert level

The European Centre for Disease Prevention and Control (ECDC) on Friday raised its risk level for mpox, a day after global health officials confirmed the

News|US

J&J's chemotherapy-free treatment for lung cancer gets US approval

The U.S.

J&J's chemotherapy-free treatment for lung cancer gets US approval
Business|Finance|Stock Markets|US

Lilly appoints insider as finance chief amid rising investments to boost capacity

U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat

Lilly appoints insider as finance chief amid rising investments to boost capacity
Health|News

Missouri health worker who had contact with bird flu patient develops symptoms, US officials report

A second Missouri healthcare worker who had contact with a hospitalized patient infected with bird flu developed mild respiratory symptoms but was not

Missouri health worker who had contact with bird flu patient develops symptoms, US officials report
Business|Finance|Health|Stock Markets|US

Cancer drug sales lift J&J past Wall Street expectations

Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly results that beat

Cancer drug sales lift J&J past Wall Street expectations
Science|World

More time and money needed to wipe out polio, global group says

The Global Polio Eradication Initiative (GPEI) needs more funds and has pushed back by three years its target to officially wipe out all forms of the disease, officials

More time and money needed to wipe out polio, global group says
Business|Finance|Health|US

Pfizer CEO defends turnaround strategy as activist pressures management

Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround

Pfizer CEO defends turnaround strategy as activist pressures management
Business|Finance|Health|US

Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot always fill them because

Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

Follow